WGS
Genedx Holdings Corp. Health Care Services-Health Services Russell 3000
$69.06Close
$2.0BMarket cap
$34.51 – $167.5152-week range
Nov 9, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 2 of 8 trend conditions
- Lagging the market RS 22 · weaker than 78% of stocks over 12 months
- Far from its high 59% below its 52-week high
- Earnings shrinking EPS −264% year on year
- Results soon Nov 9, 2026, in 8 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
59%
1wk
up 23.0%
price change
1mo
down 4.5%
price change
12-month return
down 47%
market up 11% ·
its own down 58%
F-score
6 / 9
Mixed
Altman Z″
-5.22
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
6.6×
price / book
Earnings yield
down 0.7%
EBIT / enterprise value
Cheaper than
25%
of the market · expensive
Revenue growth
up 40%
year on year
EPS growth
down 264%
latest quarter
Sales growth
up 11%
latest quarter · -6 pts
ROE
down 8%
return on equity
Free cash margin
up 3%
$14.3M FCF
D/E
0.16
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- not yet profitable on its assets
- short-term liquidity weakened
- issued more shares
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- FCF turned positive ($-34M → $14M)
- Long-term debt down 7% ($0.1B → $0.0B)
- Gross margin 63.6% → 69.7%
Trade setup
ATR%
8.3%
$5.73 a day · 2×ATR $57.60
RS
22 / 99
vs the universe
Trend
2 / 8
trend template
Relative volume
1.2×
vs 50-day average
Up/down volume
0.89
50 sessions
Implied move
—
no option chain · report Nov 9, 2026
Contractions
2
41% → 24%
Pivot
$72.70
5.0% below
Volume dry-up
1.3×
10 vs 50 sessions
Trend template · 2 of 8
- 50-day average above the 150 and 200-day: passes
- At least 30% above the 52-week low: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Shareholders diluted The share count rose 4.4% over the year, from 28m to 29m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 3, 2026
Last shock
Oct 23, 2026-16% in one session3.7× volumeno filing matched+23% since
Financials
- Gross 70%
- Net -5%
- Free cash 3%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $179.3M | $212.2M | $234.7M | $202.6M | $305.4M | $427.5M |
| Gross margin | 2% | -8% | -11% | 44% | 64% | 70% |
| Operating income | -$242.0M | -$446.1M | -$667.7M | -$180.6M | -$23.2M | -$13.1M |
| Net income | -$241.3M | -$245.4M | -$549.0M | -$175.8M | -$52.3M | -$21.0M |
| Net margin | -135% | -116% | -234% | -87% | -17% | -5% |
| Earnings per share | -$1,567,855.52 | -$75.68 | -$53.63 | -$7.23 | -$1.94 | -$0.73 |
| Free cash flow | -$117.2M | -$199.8M | -$326.3M | -$185.4M | -$34.0M | $14.3M |
| Free cash margin | -65% | -94% | -139% | -92% | -11% | 3% |
| Cash | $108.1M | $400.6M | $123.9M | $99.7M | $85.2M | $105.0M |
| Long-term debt | $19.0M | $11.0M | $6.2M | $52.7M | $51.9M | $48.2M |
| Shareholders' equity | -$330.1M | $388.1M | $253.7M | $228.0M | $245.2M | $308.2M |
| Shares outstanding | — | 7.28m | 11.77m | 25.98m | 28.02m | 29.25m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 3, 2026 | Quarterly ↗ | Jun 30, 2026 | 34d |
| May 4, 2026 | Quarterly ↗ | Mar 31, 2026 | 34d |
| Feb 23, 2026 | Annual ↗ | Dec 31, 2025 | 54d |
| Oct 28, 2025 | Quarterly ↗ | Sep 30, 2025 | 28d |
| Jul 29, 2025 | Quarterly ↗ | Jun 30, 2025 | 29d |
| Apr 30, 2025 | Quarterly ↗ | Mar 31, 2025 | 30d |
| Feb 20, 2025 | Annual ↗ | Dec 31, 2024 | 51d |
| Oct 29, 2024 | Quarterly ↗ | Sep 30, 2024 | 29d |
| Jul 30, 2024 | Quarterly ↗ | Jun 30, 2024 | 30d |
| Apr 29, 2024 | Quarterly ↗ | Mar 31, 2024 | 29d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 3, 2026 | Results ↗ |
| Jun 23, 2026 | Shareholder vote ↗ |
| Jun 16, 2026 | Director or officer change · Regulation FD ↗ |
| May 4, 2026 | Results ↗ |
| Mar 2, 2026 | Material agreement · Agreement ended · New obligation ↗ |
| Feb 23, 2026 | Results ↗ |
| Jan 12, 2026 | Results · Regulation FD ↗ |
| Oct 28, 2025 | Results ↗ |
| Sep 18, 2025 | Director or officer change ↗ |
| Jul 29, 2025 | Results ↗ |
| Jun 18, 2025 | Shareholder vote ↗ |
| Apr 30, 2025 | Results ↗ |